908 Devices (MASS) Debt Ratio (2020 - 2026)

908 Devices (MASS) posted quarterly Debt Ratio of 0.12 for Q1 2026, up 42.35% quarter-over-quarter from 0.08 in Q4 2025.

908 Devices (MASS) Debt Ratio (2020 - 2026) Analysis & Trends

908 Devices (MASS) has reported Debt Ratio for 6 consecutive years, with 0.12 the latest figure, recorded in Q1 2026.

In Q1 2026, Debt Ratio changed N/A year-over-year to 0.12; the TTM figure through Mar 2026 stood at 0.12 (changed N/A YoY), while the FY2025 annual figure was 0.08, changed N/A from the prior year.
Debt Ratio climbed to 0.12 in Q1 2026 per MASS's latest filing, from 0.08 in the prior quarter.
Across five years, Debt Ratio topped out at 0.12 in Q3 2025 and bottomed at 0.0 in Q4 2023.
Historically, Debt Ratio has averaged 0.05 across 4 years, with a median of 0.06 in 2022.
Annual changes were most pronounced in 2022 — Debt Ratio rose 16.46% — and 2023, when it slumped 96.32%.
908 Devices' Debt Ratio stood at 0.07 in 2022, then sank by 96.32% to 0.0 in 2023, then surged by 3322.69% to 0.08 in 2025, then soared by 42.35% to 0.12 in 2026.
Business Quant data shows MASS's Debt Ratio at 0.12 in Q1 2026, 0.08 in Q4 2025, and 0.12 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	0.30
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	0.31
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	0.30
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	0.04
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	0.28
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	0.18
10	908 Devices	395.76 Mn	294.23 Mn	8.34 Mn	0.14

Download Data